5-Aminolevulinic acid has to cross the tumour cells through the transporters, such as peptide transporter 2 (PEPT2), which is the primary transporter responsible for the astrocytic uptake of 5-ALA (Rodriguez et al, 2006; Xiang et al, 2006). Here, SLC15A2 is linked to neoplasm.